Progression to complete retinal pigment epithelium and outer retinal atrophy (cRORA): post hoc analysis of the GATHER1 trial

Fleckenstein M, Mitchell P, Freund KB, Sadda S, Holz FG, Brittain C, Henry EC, Ferrara D (2018) The progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125:369–390. https://doi.org/10.1016/j.ophtha.2017.08.038

Article  PubMed  Google Scholar 

Holz FG, Strauss EC, Schmitz-Valckenberg S, van Lookeren Campagne M (2014) Geographic atrophy: clinical features and potential therapeutic approaches. Ophthalmology 121:1079–1091. https://doi.org/10.1016/j.ophtha.2013.11.023

Boyer DS, Schmidt-Erfurth U, van Lookeren Campagne M, Henry EC, Brittain C (2017) The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target. Retina (Philadelphia, Pa) 37:819–835. https://doi.org/10.1097/IAE.0000000000001392

Ferris FL 3rd, Wilkinson CP, Bird A, Chakravarthy U, Chew E, Csaky K, Sadda SR, Beckman Initiative for Macular Research Classification Committee (2013) Clinical classification of age-related macular degeneration. Ophthalmology 120:844–851. https://doi.org/10.1016/j.ophtha.2012.10.036

Article  PubMed  Google Scholar 

Carlton J, Barnes S, Haywood A (2019) Patient perspectives in geographic atrophy (GA): exploratory qualitative research to understand the impact of GA for patients and their families. Br Ir Orthopt J 15:133–141. https://doi.org/10.22599/bioj.137

Article  PubMed  PubMed Central  Google Scholar 

Chakravarthy U, Bailey CC, Johnston RL, McKibbin M, Khan RS, Mahmood S, Downey L, Dhingra N, Brand C, Brittain CJ, Willis JR, Rabhi S, Muthutantri A, Cantrell RA (2018) Characterizing disease burden and progression of geographic atrophy secondary to age-related macular degeneration. Ophthalmology 125:842–849. https://doi.org/10.1016/j.ophtha.2017.11.036

Article  PubMed  Google Scholar 

Patel PJ, Ziemssen F, Ng E, Muthutantri A, Silverman D, Tschosik EA, Cantrell RA (2020) Burden of illness in geographic atrophy: a study of vision-related quality of life and health care resource use. Clin Ophthalmol 14:15–28. https://doi.org/10.2147/OPTH.S226425

Article  PubMed  PubMed Central  Google Scholar 

IzervayTM (2023) Package insert. Iveric bio, Inc

Syfovre® (2023) Package insert. Apellis Pharmaceuticals, Inc

Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP (2003) Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 48:257–293. https://doi.org/10.1016/s0039-6257(03)00030-4

Article  PubMed  Google Scholar 

Toomey CB, Johnson LV, Bowes Rickman C (2018) Complement factor H in AMD: bridging genetic associations and pathobiology. Prog Retin Eye Res 62:38–57. https://doi.org/10.1016/j.preteyeres.2017.09.001

Article  CAS  PubMed  Google Scholar 

Garred P, Tenner AJ, Mollnes TE (2021) Therapeutic targeting of the complement system: from rare diseases to pandemics. Pharmacol Rev 73:792–827. https://doi.org/10.1124/pharmrev.120.000072

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaffe GJ, Westby K, Csaky KG, Monés J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA (2021) C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2/3 trial. Ophthalmology 128:576–586. https://doi.org/10.1016/j.ophtha.2020.08.027

Article  PubMed  Google Scholar 

Patel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM (2023) Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 37:3551–3557. https://doi.org/10.1038/s41433-023-02497-w

Guymer RH, Rosenfeld PJ, Curcio CA, Holz FG, Staurenghi G, Freund KB, Schmitz-Valckenberg S, Sparrow J, Spaide RF, Tufail A, Chakravarthy U, Jaffe GJ, Csaky K, Sarraf D, Mones JM, Tadayoni R, Grunwald J, Bottoni F, Liakopoulos S, Pauleikhoff D, Pagliarini S, Chew EY, Viola F, Fleckenstein M, Blodi BA, Lim TH, Chong V, Lutty J, Bird AC, Sadda SR (2020) Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: Classification of Atrophy Meeting Report 4. Ophthalmology 127:394–409. https://doi.org/10.1016/j.ophtha.2019.09.035

Article  PubMed  Google Scholar 

Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng CB, Jaffe GJ, Liakopoulos S, Mones JM, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Staurenghi G (2018) Consensus definition for atrophy associated with age-related macular degeneration on OCT: Classification of Atrophy Report 3. Ophthalmology 125:537–548. https://doi.org/10.1016/j.ophtha.2017.09.028

Article  PubMed  Google Scholar 

Hogg RE, Wright DM, Quinn NB, Muldrew KA, Hamill B, Smyth L, McKnight AJ, Woodside J, Tully MA, Cruise S, McGuinness B, Young IS, Kee F, Peto T, Chakravarthy U (2022) Prevalence and risk factors for age-related macular degeneration in a population-based cohort study of older adults in Northern Ireland using multimodal imaging: NICOLA study. Br J Ophthalmol https://doi.org/10.1136/bjo-2021-320469

Article  PubMed  Google Scholar 

Holz FG, Sadda SR, Staurenghi G, Lindner M, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Curcio CA, Danis R, Fleckenstein M, Freund KB, Grunwald J, Guymer R, Hoyng CB, Jaffe GJ, Liakopoulos S, Mones JM, Oishi A, Pauleikhoff D, Rosenfeld PJ, Sarraf D, Spaide RF, Tadayoni R, Tufail A, Wolf S, Schmitz-Valckenberg S, CAM group (2017) Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from Classification of Atrophy Consensus Meetings. Ophthalmology 124:464–478. https://doi.org/10.1016/j.ophtha.2016.12.002

Article  PubMed  Google Scholar 

Wu Z, Luu CD, Ayton LN, Goh JK, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH (2014) Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration. Ophthalmology 121:2415–2422. https://doi.org/10.1016/j.ophtha.2014.06.034

Article  PubMed  Google Scholar 

Au A, Santina A, Abraham N, Levin MF, Corradetti G, Sadda S, Sarraf D (2022) Relationship between drusen height and OCT biomarkers of atrophy in non-neovascular AMD. Invest Ophthalmol Vis Sci 63:24. https://doi.org/10.1167/iovs.63.11.24

Article  PubMed  PubMed Central  Google Scholar 

Ouyang Y, Heussen FM, Hariri A, Keane PA, Sadda SR (2013) Optical coherence tomography-based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration. Ophthalmology 120:2656–2665. https://doi.org/10.1016/j.ophtha.2013.05.029

Article  PubMed  Google Scholar 

Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, Smith RJ, Silvestri G, Russell SR, Klaver CC, Barbazetto I, Chang S, Yannuzzi LA, Barile GR, Merriam JC, Smith RT, Olsh AK, Bergeron J, Zernant J, Merriam JE, Gold B, Dean M, Allikmets R (2005) A common haplotype in the complement regulatory gene factor h (hf1/cfh) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA 102:7227–7232. https://doi.org/10.1073/pnas.0501536102

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson LV, Ozaki S, Staples MK, Erickson PA, Anderson DH (2000) A potential role for immune complex pathogenesis in drusen formation. Exp Eye Res 70:441–449. https://doi.org/10.1006/exer.1999.0798

Article  CAS  PubMed  Google Scholar 

Loyet KM, Deforge LE, Katschke KJ Jr, Diehl L, Graham RR, Pao L, Sturgeon L, Lewin-Koh SC, Hollyfield JG, van Lookeren Campagne M (2012) Activation of the alternative complement pathway in vitreous is controlled by genetics in age-related macular degeneration. Invest Ophthalmol Vis Sci 53:6628–6637. https://doi.org/10.1167/iovs.12-9587

Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134:411–431. https://doi.org/10.1016/s0002-9394(02)01624-0

Article  CAS  PubMed  Google Scholar 

Mullins RF, Schoo DP, Sohn EH, Flamme-Wiese MJ, Workamelahu G, Johnston RM, Wang K, Tucker BA, Stone EM (2014) The membrane attack complex in aging human choriocapillaris: relationship to macular degeneration and choroidal thinning. Am J Pathol 184:3142–3153. https://doi.org/10.1016/j.ajpath.2014.07.017

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corradetti G, Corvi F, Nittala MG, Nassisi M, Alagorie AR, Scharf J, Lee MY, Sadda SR, Sarraf D (2021) Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration. Can J Ophthalmol 56:325–334. https://doi.org/10.1016/j.jcjo.2021.01.005

Article  PubMed  Google Scholar 

Nittala MG, Metlapally R, Ip M, Chakravarthy U, Holz FG, Staurenghi G, Waheed N, Velaga SB, Lindenberg S, Karamat A, Koester J, Ribeiro R, Sadda S (2022) Association of pegcetacoplan with progression of incomplete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration: a post hoc analysis of the FILLY randomized clinical trial. JAMA Ophthalmol 140:243–249. https://doi.org/10.1001/jamaophthalmol.2021.6067

Article  PubMed  PubMed Central  Google Scholar 

留言 (0)

沒有登入
gif